InvestorsHub Logo
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

Re: mick post# 1626

Saturday, 06/30/2018 2:07:15 PM

Saturday, June 30, 2018 2:07:15 PM

Post# of 2001
our buyer/ PRESS RELEASE 2018/06/18
Continued discussions with FDA on proposed remetinostat phase III design results in delay in planned start of study
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions...

our buyer
http://www.medivir.com/investors/press-releases